中药联合耳穴压豆治疗肝火亢盛型高血压的临床优势评价  

Evaluation of Clinical Advantages of Chinese Medicine Combined with Ear-point Pressure Bean in the Treatment of Liver Fire Hyperactivity Type Hypertension

作　　者：王南萍 邓国法 WANG Nanping;DENG Guofa(Department of Internal Medicine,Suzhou Industrial Park Xinghu Hospital,Suzhou,Jiangsu Province,215000 China)

机构地区：[1]苏州工业园区星湖医院内科,江苏苏州215000

出　　处：《系统医学》2023年第13期6-10,共5页Systems Medicine

摘　　要：目的 评估中药联合耳穴压豆治疗肝火亢盛型高血压患者的临床应用优势。方法 以2022年1月—2023年1月于苏州工业园区星湖医院门诊就诊的患者60例肝火亢盛型高血压病患者为观察对象,入组后所有患者均常规西药治疗,以随机数表法从患者中筛取30例作为观察组,结合中药联合耳穴压豆联合治疗,剩余30例患者作为对照组(苯磺酸左旋氨氯地平片药物治疗),对比血压控制效果,中医症候积分改善效果,临床治疗效果,治疗不良反应发生情况指标。结果 治疗后,观察组中患者血压指标对比,不同时间/不同基准维度测定值均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组中患者眩晕头痛积分(1.41±0.34)分、急躁易怒积分(1.15±0.27)分、面红目赤积分(1.38±0.26)分、口干口苦积分(1.54±0.48)分、便秘积分(1.06±0.24)分均低于治疗前的(3.25±0.74)分、(3.51±0.42)分、(3.22±0.68)分、(3.53±0.41)分、(2.84±0.59)分,差异有统计学意义(t=12.375、25.888、13.843、17.266、15.306,P<0.05);观察组不良反应发生率(3.33%)低于对照组(6.67%),但差异无统计学意义(χ^(2)=0.000,P>0.05)。结论 将中药联合耳穴压豆治疗技术引入肝火亢盛型患者中,对于血压、中医证候积分的改善作用积极、显著,保证了有效性,突出了安全性,价值明显,推荐参考使用。Objective To evaluate the clinical application advantage of Chinese medicine combined with ear-point pressure bean therapy for patients with hypertension caused by liver fire hyperactivity.Methods A total of sixty pa⁃tients with liver fire hyperactivity type hypertension were enrolled in the study,all of whom were outpatient patients of Suzhou Industrial Park Xinghu Hospital from January 2022 to January 2023.After admission,all patients were treated with conventional western medicine.Thirty patients were selected from the patients by random number table method as the observation group,combined with Chinese medicine and ear-point pressure bean combined treatment,and the remaining thirty patients were treated as the control group(levamlodipine besylate tablet).The effect of blood pressure control,the improvement effect of TCM syndrome score,the clinical treatment effect,and the occurrence index of therapeutic adverse reactions were compared.Results After treatment,the blood pressure index in observation group was lower than that in control group at different time/benchmark dimension,and the difference was statistically signifi⁃cant(P<0.05).After treatment,the score of dizziness and headache in the observation group was(1.41±0.34)points,irritability and irritability score was (1.15±0.27) points, redness and red eyes score was (1.38±0.26) points, dry mouth and bitter mouth score was (1.54±0.48) points, constipation score was (1.06±0.24) points, all lower than the score of before treatment (3.25±0.74) points, (3.51±0.42) points, (3.22±0.68) points, (3.53±0.41) points, and (2.84±0.59) points, and the difference was statistically significant (t=12.375, 25.888, 13.843, 17.266, 15.306, P<0.01). The sinci⁃ dence rate of adverse reaction indexes in the observation group (3.33%) was lower than that in the control group (6.67%), but the difference was not statistically significant (χ2=0.000, P>0.05). Conclusion The introduction of Chi⁃ nese medicine combined with ear-point pressure bean treatment technology

关 键 词：中药 耳穴压豆 肝火亢盛 高血压病 临床优势 

分 类 号：R4[医药卫生—临床医学]